This article discusses the following editorial revisions to the guidelines for determining the medical decision-making (MDM) of an evaluation and management (E/M) service provided on and after January 1, 2027: Definitions of chronic illness Documentation of the risk Definition of prescription drug management Definition of parenteral controlled substances
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: